abstract |
The present invention relates to novel pharmaceutical compositions comprising nicotinic acid and / or nicotinamide and / or related compounds for beneficially affecting gut microbiota and blood lipid levels. In certain embodiments, the pharmaceutical composition is partially or completely released into the lower small intestine and / or large intestine. |